Custom mRNA vaccine targets biliary cancer recurrence
Disease control
Recruiting now
This trial tests a personalized mRNA vaccine called iNeo-Vac-R01 in 20 adults with biliary cancer who have had surgery to remove their tumors. The vaccine is designed to train the immune system to attack cancer cells based on each patient's unique tumor markers. The main goal is …
Phase: PHASE1, PHASE2 • Sponsor: Yifan Wang • Aim: Disease control
Last updated May 18, 2026 12:11 UTC